Inhibikase Therapeutics, Inc.

IKT·NasdaqCM·Healthcare
Compare
1.5650+0.0850 (+5.74%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.4800
Open1.5600
Day range1.51001.6000
52-week range1.39002.6100
Off day high−2.19%
Off 52-week high−40.04%
Volume675.40K
Avg. volume (3M)564.36K
Market cap218.37M
EPS (TTM)-0.4300
Forward P/E-3.73
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.94
Shares outstanding139.54M
Short interest21.90% of float
Earnings dateNov 13, 2026 (est.)
Analyst target5.5500
Profit margin0.00%

Against its peers

Compare in full ›
IKT IMRX AGMB BBOT VCRE IVA
Market cap 218.37M 243.51M 337.35M 184.40M 265.87M 914.17M
P/E (TTM) — — — — — —
Forward P/E -3.7 -3.0 -3.4 -0.8 — -5.2
Price/book 1.8 1.4 2.7 0.6 — 13.8
Dividend yield — — — — — —
1-year change −12.94% −43.20% −53.24% −81.22% −41.91% −7.42%
Today +5.74% +2.17% 0.00% −0.86% +1.18% −3.97%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All IKT news ›

From the 4Search news index, newest first.

In the news

7mentions in 30 days
5with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance